250 related articles for article (PubMed ID: 20353779)
1. The endocannabinoid system in gp120-mediated insults and HIV-associated dementia.
Bari M; Rapino C; Mozetic P; Maccarrone M
Exp Neurol; 2010 Jul; 224(1):74-84. PubMed ID: 20353779
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases.
Maccarrone M; Battista N; Centonze D
Prog Neurobiol; 2007 Apr; 81(5-6):349-79. PubMed ID: 17276576
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the endocannabinoid system: neuroprotection or neurotoxicity?
Fowler CJ; Rojo ML; Rodriguez-Gaztelumendi A
Exp Neurol; 2010 Jul; 224(1):37-47. PubMed ID: 20353772
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system in neuropathological states.
Orgado JM; Fernández-Ruiz J; Romero J
Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
[TBL] [Abstract][Full Text] [Related]
5. The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis.
Centonze D; Rossi S; Finazzi-Agrò A; Bernardi G; Maccarrone M
Int Rev Neurobiol; 2007; 82():171-86. PubMed ID: 17678961
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
Onaivi ES
Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system and amyloid-related diseases.
Ruiz-Valdepeñas L; Benito C; Tolón RM; Martínez Orgado JA; Romero J
Exp Neurol; 2010 Jul; 224(1):66-73. PubMed ID: 20353781
[TBL] [Abstract][Full Text] [Related]
9. Lipid rafts: a nexus for endocannabinoid signaling?
McFarland MJ; Barker EL
Life Sci; 2005 Aug; 77(14):1640-50. PubMed ID: 15978630
[TBL] [Abstract][Full Text] [Related]
10. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system: a new entry in remote cell death mechanisms.
Viscomi MT; Oddi S; Latini L; Bisicchia E; Maccarrone M; Molinari M
Exp Neurol; 2010 Jul; 224(1):56-65. PubMed ID: 20353775
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
Rossi S; Bernardi G; Centonze D
Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
14. Homeostatic changes of the endocannabinoid system in Parkinson's disease.
Pisani V; Madeo G; Tassone A; Sciamanna G; Maccarrone M; Stanzione P; Pisani A
Mov Disord; 2011 Feb; 26(2):216-22. PubMed ID: 21412829
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system and gut-brain signalling.
Storr MA; Sharkey KA
Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
[TBL] [Abstract][Full Text] [Related]
16. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.
Witting A; Chen L; Cudaback E; Straiker A; Walter L; Rickman B; Möller T; Brosnan C; Stella N
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6362-7. PubMed ID: 16571660
[TBL] [Abstract][Full Text] [Related]
17. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 infection and AIDS: consequences for the central nervous system.
Kaul M; Zheng J; Okamoto S; Gendelman HE; Lipton SA
Cell Death Differ; 2005 Aug; 12 Suppl 1():878-92. PubMed ID: 15832177
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
Bisogno T; Di Marzo V
CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
[TBL] [Abstract][Full Text] [Related]
20. The polarised life of the endocannabinoid system in CNS development.
Anavi-Goffer S; Mulder J
Chembiochem; 2009 Jul; 10(10):1591-8. PubMed ID: 19533710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
